Details of the Drug

General Information of Drug (ID: DMWB310)

• Drug Name: Satralizumab

Indication

Disease Entry	ICD 11	Status	REF
Neuromyelitis optica spectrum disorder	8E4A.0	Approved	[1]

• Affected Organisms: Humans and other mammals
• ATC Code:
  L04AC19: Satralizumab
  L04AC: Interleukin inhibitors
  L04A: IMMUNOSUPPRESSANTS
  L04: IMMUNOSUPPRESSANTS
  L: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
• Cross-matching ID:
  UNII: YB18NF020M
  DrugBank ID: DB15762
  TTD ID: D0MD0T

References

• [1] Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2020